Vioxx Will Weigh as Drugmakers Consider Strategy
496294
The withdrawal of Merck &amp; Co. Inc.&#39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators
177898
Merck, the maker of the arthritis drug Vioxx is facing a nationwide legal assault as lawyers representing thousands of people injured or killed by the painkiller meet next week to set the groundwork for a massive action against the drug maker.
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
735299
WASHINGTON -- The nation&#39;s largest health management organization is considering changing how it prescribes Vioxx after a government study showed that high doses of the arthritis drug tripled patients&#39; risk of heart attacks and sudden cardiac death.
184964
Ever since Vioxx was pulled from the market over concerns about a risk of heart attack and stroke, arthritis patients have been asking doctors one question: What should I do now?
279051
Hundreds of plaintiffsâ lawyers who claim that people were injured or killed by the painkiller Vioxx, plan to meet next week to lay the groundwork for a nationwide legal assault against the drugâs maker, Merck.
608096
It might not just be Vioxx that carries a risk of heart problems. Scientists and European regulators say users of similar pain-relief medications also may have cause for concern.
257427
Since Vioxx was pulled off the market last week, arthritis suffers have had to make difficult choices about alternatives for pain relief.
14152
Drugs in the same category as Merck &amp; Co. Inc.&#39;s withdrawn Vioxx painkiller will get close scrutiny to see if they can also cause heart attacks, US Food and Drug Administration officials said on Thursday.
668955
A new study linking high doses of Vioxx to an increased risk of heart attacks and sudden cardiac deaths has re-ignited a running debate about the safety of the arthritis drug.
212028
Drug companies rushing to fill the vacuum left by Merck &amp; Co.&#39;s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing
646011
Drugmaker Merck &amp; Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that
217345
Merck&#39;s (MRK:NYSE - news - research) withdrawn painkiller, Vioxx, could soon leave pharmacy benefit manager (PBM) Medco (MHS:NYSE - news - research) with its own headaches.
286900
The US Food and Drug Administration says it plans to convene a panel of experts in February to discuss the safety of painkillers in the same class as the now-withdrawn drug Vioxx, but one member of the panel was asked not to come.
428395
Merck & Co Inc. is evaluating why its withdrawn painkiller Vioxx raises the chance of heart attack and stroke, but it has not found a mechanism of action, a company official said on Monday.
665220
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis drug pulled from the market last week after a study suggested it doubled the risk of heart attacks and strokes.
422988
The withdrawal of Vioxx from the market in September and more recent concerns about its cousin Bextra have raised safety questions about this entire class of painkillers